Zusammenfassung
Mastozytosen sind seltene Erkrankungen, die durch eine meist gutartige Vermehrung und Akkumulation von Mastzellen in verschiedenen Geweben charakterisiert sind. Kinder sind vornehmlich von einer isolierten Hautmastozytose betroffen, die sich in einigen Aspekten von der kutanen Mastozytose des Erwachsenenalters unterscheidet. Mit Ausnahme der seltenen diffusen kutanen Mastozytose des Kindesalters lassen sich in der Regel bei der kindlichen Mastozytose keine Mastzellinfiltrate im Knochenmark oder anderen extrakutanen Organsystemen nachweisen. Die Prognose der kindlichen Mastozytose ist im Regelfall sehr günstig. Im Gegensatz zu Mastozytosen des Erwachsenenalters, die meist chronisch-stabil oder langsam progredient verlaufen, sind die Mastozytosen des Kindesalters häufig transient und selbstlimitierend. In dieser Übersicht werden die verschiedenen Formen kindlicher Mastozytosen, aktuelle Erkenntnisse zu deren Pathogenese sowie Gemeinsamkeiten und Unterschiede zu Mastozytosen des Erwachsenenalters dargestellt.
Abstract
Mastocytoses are a group of rare diseases characterized, in most cases, by a benign proliferation and accumulation of mast cells in different tissues. In children, mastocytosis affects usually exclusively the skin and differs in many aspects from adult-onset mastocytosis. Except for diffuse cutaneous mastocytosis, which is an uncommon subtype of childhood-onset mastocytosis, involvement of the bone marrow or additional extracutaneous organs is rarely seen in children. The prognosis of childhood-onset mastocytosis is usually very good. Compared to adult patients who most commonly experience chronic-stable or slowly progressive disease, mastocytosis in children is mostly transient and self-limiting. In this review, we present and discuss the subtypes of childhood-onset mastocytosis, recent advances in the understanding of their pathogenesis as well as similarities and differences between adult- and childhood-onset mastocytosis.
Literatur
Amon U, Hartmann K, Horny Hp et al (2010) Mastocytosis – an update. J Dtsch Dermatol Ges 8:695–711, quiz 712
Bodemer C, Hermine O, Palmerini F et al (2010) Pediatric mastocytosis is a clonal disease associated with D816 V and other activating c-KIT mutations. J Invest Dermatol 130:804–815
Brockow K, Jofer C, Behrendt H et al (2008) Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 63:226–232
Brockow K, Ring J (2011) Update on diagnosis and treatment of mastocytosis. Curr Allergy Asthma Rep 11:292–299
Caksen H, Odabas D, Oner AF et al (2003) Use of interferon alpha-2b and prednisolone in the treatment of severe intractable diarrhea in a child with systemic mastocytosis. Pediatr Int 45:751–754
Carter MC, Uzzaman A, Scott LM et al (2008) Pediatric mastocytosis: routine anesthetic management for a complex disease. Anesth Analg 107:422–427
Correia O, Duarte AF, Quirino P et al (2010) Cutaneous mastocytosis: two pediatric cases treated with topical pimecrolimus. Dermatol Online J 16:8
Gonzalez De Olano D, De La Hoz Caballer B, Nunez Lopez R et al (2007) Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA). Clin Exp Allergy 37:1547–1555
Hartmann K, Biedermann T, Brockow K et al (2009) Leitlinie Mastozytose. Allergologie 32:199–213
Hartmann K, Henz BM (2002) Classification of cutaneous mastocytosis: a modified consensus proposal. Leuk Res 26:483–484, author reply 485–486
Hartmann K, Metcalfe DD (2000) Pediatric mastocytosis. Hematol Oncol Clin North Am 14:625–640
Hartmann K, Wardelmann E, Ma Y et al (2005) Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis. Gastroenterology 129:1042–1046
Heide R, Beishuizen A, De Groot H et al (2008) Mastocytosis in children: a protocol for management. Pediatr Dermatol 25:493–500
Heide R, Zuidema E, Beishuizen A et al (2009) Clinical aspects of diffuse cutaneous mastocytosis in children: two variants. Dermatology 219:309–315
Hoffmann KM, Moser A, Lohse P et al (2008) Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation. Blood 112:1655–1657
Horny HP, Sotlar K, Valent P (2007) Mastocytosis: state of the art. Pathobiology 74:121–132
Kambe N, Longley BJ, Miyachi Y et al (2010) KIT masters mast cells in kids, too. J Invest Dermatol 130:648–650
Koga H, Kokubo T, Akaishi M et al (2011) Neonatal onset diffuse cutaneous mastocytosis: a case report and review of the literature. Pediatr Dermatol 28:542–546
Konrad FM, Unertl KE, Schroeder TH (2009) Mastocytosis. A challenge in anaesthesiology. Anaesthesist 58:1239–1243
Lanternier F, Cohen-Akenine A, Palmerini F et al (2008) Phenotypic and genotypic characteristics of mastocytosis according to the age of onset. PLoS One 3:e1906
Parker RI (2009) Pediatric mast cell disease: What’s the big (hematologic) deal? Pediatr Blood Cancer 53:527–528
Salpietro CD, Briuglia S, Cutrupi MC et al (2009) Apparent third patient with cutaneous mastocytosis, microcephaly, conductive hearing loss, and microtia. Am J Med Genet A 149A:2270–2273
Siebenhaar F, Kuhn W, Zuberbier T et al (2007) Successful treatment of cutaneous mastocytosis and Meniere disease with anti-IgE therapy. J Allergy Clin Immunol 120:213–215
Uzzaman A, Maric I, Noel P et al (2009) Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology. Pediatr Blood Cancer 53:629–634
Valent P, Horny HP, Escribano L et al (2001) Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 25:603–625
Vardiman JW, Thiele J, Arber DA et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114:937–951
Vieira Dos Santos R, Magerl M, Martus P et al (2010) Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus. Br J Dermatol 162:674–676
Yang Y, Letard S, Borge L et al (2010) Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations. Blood 116:1114–1123
Danksagung
Wir danken Nicole Schoepke, Tatevik Ohanyan, Johanna Meinhard und Karola Stieler für die kritische Durchsicht und Korrektur des Manuskripts.
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Siebenhaar, F., Weller, K., Blume-Peytavi, U. et al. Mastozytosen im Kindesalter. Hautarzt 63, 104–111 (2012). https://doi.org/10.1007/s00105-011-2201-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-011-2201-2